- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Treatment with Zilver PTX Drug Eluting Stent (DES) in femoropopliteal lesions
Total 42 results
-
Skane University HospitalCompletedVascular Diseases
-
Fundacja Ośrodek Badań MedycznychCompletedMyocardial InfarctionPoland, Slovenia
-
Yonsei UniversityUnknownFemoropopliteal Artery DiseaseKorea, Republic of
-
Cook Group IncorporatedWilliam Cook Europe; MED Institute, Incorporated; Cook Japan IncorporatedCompletedPeripheral Vascular DiseasesUnited States, Japan, Germany
-
Nantes University HospitalTerminatedPeripheral Arterial Disease | Femoropopliteal LesionsFrance
-
Cook Research IncorporatedCompleted
-
Cook Group IncorporatedCompletedPeripheral Arterial Disease (PAD)
-
Chinese PLA General HospitalUnknown
-
Maimónides Biomedical Research Institute of CórdobaInstituto de Salud Carlos IIICompletedCoronary Health DiseaseSpain
-
Instituto Dante Pazzanese de CardiologiaRecruitingPercutaneous Coronary Intervention | Myocardial Dysfunction | STEMI - ST Elevation Myocardial InfarctionBrazil
-
Cook Group IncorporatedCompleted
-
Poznan University of Medical SciencesCompleted
-
Rigshospitalet, DenmarkUnknownPeripheral Arterial DiseaseDenmark
-
North Texas Veterans Healthcare SystemTerminatedPeripheral Vascular Diseases | Chronic Total Occlusion of Artery of the ExtremitiesUnited States
-
Helsinki University Central HospitalCompletedVascular Access Complication | Restenosis, Vascular Graft | Dialysis Related Complications
-
University of Sao Paulo General HospitalCompleted
-
Provascular GmbHWilliam Cook EuropeCompletedPeripheral Artery DiseaseBelgium, Germany
-
Cook Group IncorporatedCompletedPeripheral Arterial Disease (PAD)Germany, New Zealand
-
Assiut UniversityUnknownDiabetes Mellitus, Type 2 With Acute Coronary Syndrom
-
General Administration of Military Health, TunisiaB. Braun Medical International Trading Company Ltd.RecruitingCoronary Artery Disease (CAD) | De Novo Stenosis | Percutaneous Coronary Intervention (PCI)Tunisia
-
Cathreine BVCatharina Ziekenhuis Eindhoven; St. Antonius Hospital; Medical Centre Leeuwarden and other collaboratorsRecruitingCoronary Artery Disease | Coronary Bifurcation LesionNetherlands
-
Hangzhou Tangji Medical Technology Co., Ltd.Not yet recruitingNonalcoholic Fatty Liver Disease
-
Netherlands Society for Interventional RadiologyActive, not recruitingPeripheral Vascular DiseaseNetherlands
-
Federico II UniversityAdvicePharma GroupActive, not recruitingMyocardial Infarction | Coronary Artery Disease | Acute Coronary Syndrome | Chronic Coronary SyndromeItaly
-
Institut CurieZionexaRecruiting
-
Peking University Third HospitalWest China Hospital; The Affiliated Hospital Of Guizhou Medical University; Northern... and other collaboratorsNot yet recruitingArthroplasty, Replacement, Knee
-
Translational Research in OncologyBayerRecruitingCarcinoma, HepatocellularKorea, Republic of, United States, Taiwan, Spain, Japan, France, Georgia, Germany, Turkey, Italy, Belgium, Hong Kong, Serbia
-
AHS Cancer Control AlbertaRecruitingGlioblastoma MultiformeCanada
-
Cedars-Sinai Medical CenterCompletedGlioma | Glioblastoma | Astrocytoma | Brain Tumor | Glioblastoma MultiformeUnited States
-
IGLESIAS Juan FernandoClinical Trials Unit University of BernNot yet recruitingST Elevation Myocardial InfarctionSwitzerland
-
Memorial Sloan Kettering Cancer CenterTufts Medical Center; Lahey ClinicCompleted
-
John ReneauRecruitingRecurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Recurrent Adult T-Cell Leukemia/Lymphoma | Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Refractory Adult T-Cell Leukemia/LymphomaUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedB-cell Childhood Acute Lymphoblastic Leukemia | L1 Childhood Acute Lymphoblastic Leukemia | L2 Childhood Acute Lymphoblastic Leukemia | Intermediate Risk Recurrent Childhood Acute Lymphoblastic LeukemiaUnited States, Canada, Australia, Switzerland
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Refractory T Acute Lymphoblastic Leukemia | Recurrent T Acute Lymphoblastic LeukemiaUnited States
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)CompletedAcute Myeloid Leukemia | Acute Lymphoblastic LeukemiaUnited States
-
National Cancer Institute (NCI)RecruitingDown Syndrome | B Acute Lymphoblastic Leukemia | B Lymphoblastic LymphomaUnited States, Canada, Puerto Rico, Australia, New Zealand
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingAcute Lymphoblastic Leukemia | Down Syndrome | Philadelphia Chromosome Positive | Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Childhood B Acute Lymphoblastic Leukemia | Adult B Lymphoblastic Lymphoma | Ann Arbor Stage I B Lymphoblastic Lymphoma | Ann Arbor Stage... and other conditionsUnited States, Canada, Puerto Rico, Australia, New Zealand, Switzerland, Ireland
-
National Cancer Institute (NCI)Canadian Cancer Trials GroupActive, not recruitingAcute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeUnited States, Canada, Israel, Puerto Rico
-
National Cancer Institute (NCI)Active, not recruitingB Acute Lymphoblastic Leukemia | Central Nervous System Leukemia | Testicular Leukemia | B Acute Lymphoblastic Leukemia, BCR-ABL1-LikeUnited States, Canada, Puerto Rico, Australia, New Zealand, Switzerland, Ireland
-
National Cancer Institute (NCI)Active, not recruitingT Acute Lymphoblastic Leukemia | T Lymphoblastic LymphomaUnited States, Canada, Australia, New Zealand, Switzerland
-
National Cancer Institute (NCI)Active, not recruitingB Acute Lymphoblastic Leukemia | Acute Leukemia of Ambiguous Lineage | Mixed Phenotype Acute LeukemiaUnited States, Canada, Puerto Rico, Australia